List of Articles by MeSH

BONE REMODELING

1. Šnjarić D, Kovačević M, Bešlić S, Tamarut T, Horvat J, Kuiš D. Doxycycline influence on bone remodeling after therapy of periapical lesions. Acta Stomatol Croat. 2003;37(3):376-7.
    [details]
    [close]
   Full Text

   Title in English:	Doxycycline influence on bone remodeling after therapy of periapical lesions
   Title in Croatian:	Utjecaj doksiciklina na preoblikovanje kosti nakon terapije periapeksne lezije
   Type of Article:	congress abstract
   MeSH:	PERIAPICAL DISEASES + therapy DOXYCYCLINE BONE REMODELING
   Abstract:	The aim of the study was to evaluate bone remodelling after endodontic therapy of periapical lesions combined with doxycycline administration by measuring osteoid surface, osteoid thickness, osteoclast index and inflammatory cell count in comparison with bone remodelling after endodontic therapy whithout antibiotic administration in dogs.The experiment was conducted on six mongrel dogs. Endodontic therapy was performed 35 days after artificial dental pulp exposure. A total of 30 roots were cleaned and shaped by Crown-down technique with Profile® rotary instruments and filled with Thermafill® at the lenght to the apical delta confirmed radiographically. Cavities were sealed with amalgam. Animals were then divided into group 1 (antibiotic, three animals with 21 roots) and group 2 (non-antibiotic, three animals with 17 roots). Immediately after endodontic therapy, animals in group 1 were treated by administration of doxycycline (10 mg/kg, Hiramicin, Pliva d.d., Zagreb, Croatia) for a period od12 days. All animals were sacrified 35 days after endodontic therapy and mandibles embedded in methylmetacrylate. Undemineralized sections 5 µm thick were stained with toluidine blue. The histomorphometric indices (osteoid surface, osteoid thickness, osteoclast index and inflammatory cell count) were measured by light microscopy using computer program (ISSA, Vams, Zagreb,Croatia).Osteoid thickness (group 1: 15.33 µm ± 33.49; group 2: 15.62 µm ± 7.41 ; p > 0.05) and inflammatory cell count (group 1: 117.16 ± 38.66; group 2: 111.39 ± 75.81; p > 0.05) did not show statistically significant difference. The difference between groups was statistically significant in measured indices of osteoid surface and osteoclast index.Osteoid surface was greater in group 1 (group 1: 30.56 ± 15.51; group 2: 10.34% ± 11.60; p < 0.0001). Osteoclast index was lower in group 1 (group 1: 43.13 mm - 2 ± 41.25; group 2: 111.34 mm - 2 ± 115.46 ; p < 0.0001). Statistical analysis was performed using Mann-Whitney U test.There was no difference in osteoid thickness and inflammatory cell count between the two groups. Osteoid surface was higher and osteoclast index lower in group 1 (antibiotic treated group) which indicates greater bone tissue healing potential.